logo
The Best Cities To Live In, According To The Global Liveability Index

The Best Cities To Live In, According To The Global Liveability Index

Forbes17-06-2025
The release of the 2025 Global Liveability Index from the Economist Intelligence Unit (EIU) has seen a new city take the crown as the world's most liveable. After three years at the top of the rankings, Austria's capital Vienna has finally been usurped by Denmark's capital city, Copenhagen.
Welcome to the world's best city to live in. Copenhagen achieved near perfect scores across the board.
The EIU's annual index assesses 173 locations around the world, ranking their liveability based on a variety of indicators and criteria. This ranking attempts to quantify the challenges someone might face to their lifestyle in any of the given locations, to help assess which offer the best and worst living conditions.
Each city is measured across 30+ qualitative and quantitative factors in five categories described as stability, healthcare, culture and environment, education, and infrastructure. Qualitative factors are decided by a panel of expert EIU analysts and in-city contributors. Quantitative factors are based on the relative performance of a range of external data points. Each factor is then assigned a rating as acceptable, tolerable, uncomfortable, undesirable or intolerable.
The EIU Index then assigns a score to each category, which are compiled and weighted to create an easy reference 1-100 score, where 1 is intolerable and 100 is ideal.
Copenhagen has been crowned the world's most comfortable city to live in 2025, earning perfect scores for stability, education and infrastructure. Its overall Index score reached 98 of a possible 100.
Although Vienna has lost the top spot, it remains one of the great cities to live in—or just to visit.
It beats the longstanding leader, Vienna, into second place, although the Austrian capital also scored perfectly for education and infrastructure, as well as healthcare. Vienna shares second this year with Zurich, which ranked perfectly in both the education and healthcare categories. Another Swiss city, Geneva, ranked fifth overall, showcasing the dominance of Western European cities in the index with four of the top five positions.
The only city to break that European grip is Melbourne in Australia, which takes fourth spot with an overall score of 97 out of 100. The Southern Hemisphere comes into its own for the remaining top ten places with Australia's Sydney and Adelaide in sixth and ninth places respectively, Osaka in Japan in seventh and Auckland in New Zealand in eighth. Just sneaking into the top is North America's sole representative, Vancouver.
London remains the UK's most liveable city but has dropped out of the top 50 globally.
While Western European cities dominate the Index, it's notable that all the UK cities covered—London, Manchester and Edinburgh—have dropped down the rankings and sit well outside the top ten. This is due to a combination of political instability and growing civil unrest that has impacted scores. In 2025, London dropped from 45th to 54th place, Manchester from 43rd to 52nd and Edinburgh from 59th to 64th.
The reason for Vienna's fall from the top spot comes down to its declining stability score, impacted by a variety of factors including terrorism scares, one of which saw Taylor Swift's summer 2024 concert canceled.
The 2025 Global Liveability Index Top 10
Deputy industry director at EIU, Barsali Bhattacharyya commented, 'Global liveability has remained flat over the past year, and as in 2024, scores for stability have declined at a global level. Pressure on stability has led Vienna to lose its position as the most liveable city after a three-year stint. As in 2024, stability scores have declined for western Europe and the Middle East and North Africa. In this edition, they have also declined for Asia, amid intensified threats of military conflict for cities in India and Taiwan.'
While the average overall liveability score across the Index was consistent with 2024 at 76.1 out of 100, stability scores fell by 0.2 points overall. This comes amid huge global geopolitical tensions, civil unrest and a growing global housing crisis. Conversely, the Index has also seen overall gains in scores for healthcare, education and infrastructure.
There have been some very notable movements both up and down the Index in 2025. Canadian cities in particular have suffered, with Calgary dropping from fifth place in 2024 to 18th place in 2025 after a marked drop in its healthcare score. This has impacted all four Canadian cities in the Index after the well-publicized strain on the country's healthcare system thanks to a shortage of staff, among other factors. Toronto saw its ranking drop from 12th to 16th.
While those numbers don't look great, it's still important to look at them in context. Alongside the other 20 North America cities ranked, all reported the highest possible tier of liveability according to the Index's criteria, scoring above 80 out of 100. The highest U.S. city on the list was Honolulu in Hawaii, which ranked 23rd overall.
Improvements in healthcare and education have seen Middle Eastern cities like Al Khobar great improve liveability scores.
Moving up the Index, Al Khobar in Saudi Arabia's Persian Gulf saw the biggest leap, climbing 13 places from 148th to 135th thanks to improved healthcare and education. This reflects a trend across regions in the Middle East and North Africa, which saw the most significant global gains in overall liveability, largely driven by advancements in healthcare and education within cities in Saudi Arabia and the UAE.
Propping up the Index once again is war torn Damascus in Syria, which has seen no improvement in its liveability score despite the fall of ex-president Bashar al-Assad and subsequent regime change in December 2024. While this should increase its potential for improvement dramatically, the legacy of a years-long civil war will realistically take years to recover from.
Despite a regime change, years of civil war have left Damascus rooted to the bottom of the Global Liveability Index.
This is reflected in the significant jump to the second and third worst ranked cities, Tripoli in Libya and Dhakar in Bangladesh.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

'Menopause made me forget my name'
'Menopause made me forget my name'

Yahoo

time32 minutes ago

  • Yahoo

'Menopause made me forget my name'

"I didn't believe it could just be menopause. I thought it must be a brain tumour or dementia." Kirsty Dixon's life changed overnight when she started experiencing intense brain fog at 49 years old. Kirsty, from York, was staring at her screen at work one day, when suddenly she could not remember what she was doing. "I just asked myself 'What is my name?', and I couldn't even remember my own name. "I felt like I was going mad, I thought it was only me." The problems continued when she tried to access support. "I thought, why aren't people listening to me? "I've got something really serious going on but I can't get anyone to listen." Kirsty was told by a doctor that what she had experienced was part of the menopause. It is estimated that one in three women in the UK is going through the menopause at any given time. Kirsty, learning and development adviser at the University of York, is working to raise awareness of the lesser-known symptoms and the huge impact they can have on people's lives. "Before menopause I've always been a very bubbly person, very social, bit mischievous," she said. "Menopause came along and just put a big thunder cloud over my head. "I lost myself. The number of times my husband said 'I want my Kirsty back' while he was cuddling me and I was in floods of tears." Kirsty spent the next four years "fighting it" as she could not believe that those were menopause symptoms. Then, during lockdown, Kirsty found herself researching menopause for her work. She stumbled across an article by someone who had experienced the same symptoms as her. "I got that lightbulb moment that what I was experiencing was perfectly normal, I needed to understand it and know what I could do to help myself," she said. "I went from having this constant cloud and feeling useless, to actually owning my journey." Now aged 58, Kirsty runs two support groups for women experiencing the menopause, including a nature walking group around York, and a pop-up cafe in Acomb. They are non-profit and everyone is welcome, regardless of age or gender. She hopes the groups will encourage more people to talk about the lesser-known symptoms. "When you're going through it, it can feel so lonely," she said. "You feel like it's only you, and you think you're going mad. "One of the most important things I say to people is get your support network around you, and that's family, friends, and groups like this." Sarah Mortimer, 54, has been coming to the group since it started in 2022. She experienced an uncommon symptom of self-diagnosed burning mouth syndrome during her menopause, which involves developing blisters in the mouth with a burning feeling. "It can be really isolating, so to find groups like this is amazing," she said. "It makes a huge difference, knowing there's other people going through the same rubbish that you're going through. "It's that strength in numbers thing, and there's strength in the power of talking about the menopause." The group is based in York, but people travel from as far as Leeds, Sheffield and Beverley to attend. Kirsty says that it highlights an ongoing issue around the need for more support for people going through the menopause. "No one else was running a menopause cafe in York, so it was obviously something that was missing." She is calling for more groups like this so that people do not have to travel so far to get the support they need. "What I will say now, is as a post-menopausal woman, I am the most confident, the strongest, most creative person. "If someone said to me you can have your life again, without your menopause experience, actually, I'd say no, because it's what's made me the person I am today. "If I can get through that, I can get through anything." Listen to highlights from North Yorkshire on BBC Sounds, catch up with the latest episode of Look North or tell us a story you think we should be covering here. 'Fire service is helping me through the menopause' 'I mistook cancer signs for the menopause' What's the point of the menopause? NHS menopause advice

Summit Therapeutics Reportedly Makes $15B AstraZeneca Licensing Talks for Lung Cancer Drug
Summit Therapeutics Reportedly Makes $15B AstraZeneca Licensing Talks for Lung Cancer Drug

Yahoo

timean hour ago

  • Yahoo

Summit Therapeutics Reportedly Makes $15B AstraZeneca Licensing Talks for Lung Cancer Drug

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, Bloomberg News reported that AstraZeneca (NASDAQ:AZN) is in discussions with Summit Therapeutics for a licensing agreement concerning an experimental lung cancer drug, with a potential value of up to $15 billion. The proposed deal for the drug, which is known as ivonescimab, could involve an upfront payment of several billion dollars to Summit, in addition to future milestone payments. However, the talks are ongoing and could still fall apart. Summit might even choose to partner with a different company. Neither Summit nor AstraZeneca has officially commented on the report. A laboratory employee in a sterile environment inspecting a microscope focused on a Clostridioides difficile infection sample. Summit Therapeutics secured the rights to ivonescimab through a separate deal worth up to $5 billion with China-based Akeso in December 2022. Under that agreement, Summit gained exclusive rights to develop and commercialize ivonescimab in the US, Canada, Europe, and Japan, while Akeso (OTC:AKESF) retained rights for other regions, including China. The deal included an upfront payment of $500 million to Akeso and potential regulatory and commercial milestones of up to $4.5 billion. Summit Therapeutics Inc. (NASDAQ:SMMT) is a biopharmaceutical company that discovers, develops, and commercializes patient, physician, caregiver, and societal-friendly medicinal therapies. AstraZeneca (NASDAQ:AZN) is a biopharmaceutical company that discovers, develops, manufactures, and commercializes prescription medicines. While we acknowledge the potential of SMMT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma
Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma

Yahoo

time2 hours ago

  • Yahoo

Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma

Alvotech (NASDAQ:ALVO) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On July 1, Alvotech (NASDAQ:ALVO) and Advanz Pharma announced a commercialization agreement to distribute and supply AVT10, a biosimilar candidate to Cimzia, in Europe. A scientist in a laboratory working on drug research. The agreement is expected to support Alvotech's (NASDAQ:ALVO) strategic position in the biosimilar market while allowing increased access to high-quality biologics in Europe. This could potentially affect the market share of the current treatments in the chronic rheumatic diseases sector. Alvotech (NASDAQ:ALVO) is a biotechnology company that develops and manufactures biosimilar medicines. Headquartered in Luxembourg, the company operates in the following geographical segments: Europe, North America, Asia, and Other. While we acknowledge the potential of ALVO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store